Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J. Kyle Bruner
Adaptation to TKI Treatment Reactivates ERK Signaling in Tyrosine Kinase-Driven Leukemias and Other Malignancies
Cancer Research
Cancer Research
Oncology
Related publications
Correction To: Role of Bruton’s Tyrosine Kinase in B Cells and Malignancies
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
MerReceptor Tyrosine Kinase Signaling
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Role of Calcium-Sensitive Tyrosine Kinase Pyk2/Cak /RAFTK in Angiotensin II Induced Ras/Erk Signaling
Hypertension
Internal Medicine
STAT Signaling in the Pathogenesis and Treatment of Leukemias
Oncogene
Cancer Research
Genetics
Molecular Biology
NR2B-NMDA Receptor-Mediated Increases in Intracellular Ca2+ Concentration Regulate the Tyrosine Phosphatase, STEP, and ERK MAP Kinase Signaling
Journal of Neurochemistry
Biochemistry
Molecular Neuroscience
Cellular
SRC Tyrosine Kinase Activation by 4-Hydroxynonenal Upregulates P38, ERK/AP-1 Signaling and COX-2 Expression in YPEN-1 Cells
PLoS ONE
Multidisciplinary
Ror2 Receptor Requires Tyrosine Kinase Activity to Mediate Wnt5A Signaling
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Metastatic Adamantinoma Responds to Treatment With Receptor Tyrosine Kinase Inhibitor
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
Patient-Driven Discontinuation of Tyrosine Kinase Inhibitors: Single Institution Experience
Leukemia and Lymphoma
Cancer Research
Oncology
Hematology